CClinicalTrials.gg
CompletedNCT03247374BIO_DYSUpdated Oct 5, 2022

Bio-feedback Treatment for Dysphagic Post-stroke Patients

An interventional study of "ProComp5 Infiniti" Biofeedback and Standard Speech and Language Therapy in Dysphagia, Late Effect of Stroke and Deglutition Disorders, sponsored by IRCCS San Camillo, Venezia, Italy. Completed at 1 site in Italy. Open to participants aged 18 Years to 81 Years. Per ClinicalTrials.gov, last updated 2022-10-05.

Sponsored by IRCCS San Camillo, Venezia, Italy · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
17
Allocation
Randomized
Ages
18 Years to 81 Years
Sex
All
01

Study summary

The primary purpose of the study is to evaluate whether the effect of bio-feedback dysphagia treatment is more effective than a control treatment in post-stroke patients.

This study will be a randomized, single-blind controlled pilot study. The investigators intend to recruit 40 patients who have suffered a stroke and have dysphagia. Twenty patients will undergo training with bio-feedback (experimental group) and the other 20 patients will undergo standard training, using only verbal feedback rather than visual feedback (control group).

The authors hypothesize that in the control group the efficacy of the treatment will be lower in the absence of immediate visual feedback of strength and coordination of the swallowing act.

Read the detailed description

The procedure is divided into 5 parts:

  • Clinical and instrumental evaluation (fibroendoscopy) of swallowing functions before the treatment;
  • 25 sessions with bio feedback treatment or 25 sessions of control treatment;
  • Clinical and instrumental evaluation (fibroendoscopy) of swallowing functions after the training;
  • Clinical and instrumental evaluation (fibroendoscopy) of swallowing functions after 3 months.

Each participant will attend 5 sessions per week for a total duration of 5 weeks. The duration of each session will take 1 hour, including bio-feedback preparation that will take about 10 minutes for assembly and 5 minutes for removal. At the beginning of the bio-feedback session, a surface electrode will be applied to the mylohyoid muscle. The computer will analyze the electromyographic signal of the patient in real time and will produce visual feedback of the muscular activity on the screen. The patient will be required to swallow at a given time, with food bolus if possible, and perform maneuvers that favor swallowing strength and efficacy.

During the first session, participant will be instructed to use the tool before starting the training phase. Patients of both groups will participate in similar sessions, with classical maneuvers favoring swallowing efficacy that is effortful swallow, supraglottic swallow, and "Masako" maneuver, the first two with bolus administration, if possible. The experimental group will perform this training for 45 minutes with the support of visualization of muscle activity on the screen (biofeedback), while the control group will attend the same training for 45 minutes, but receiving verbal feedback from the speech and language therapist.

Data analysis

On the measures collected, a descriptive statistical analysis and distribution will be studied. Initial instrumental and clinical data from FOIS scale (The Functional Oral Intake Scale), PAS (Penetration-Aspiration Scale), Pooling Score (Farneti et al.); Cranial nerves test will be analyzed using parametric (t-test) and non-parametric (Wilcoxon test) tests with a p-value considered significant if \<0.05, while longitudinal variations will be analyzed using ANOVA for repeated measurements. In addition, the effect size (Cohen's d) of the difference between the instrumental and clinical evaluation scales average before and after training in both groups will be calculated. This will allow to have an estimate of training effectiveness to perform a power study and plan a wider experimental study for validating the method.

02

Conditions studied

  • Dysphagia, Late Effect of Stroke
  • Deglutition Disorders

Keywords

  • rehabilitation
  • treatment
  • biofeedback
  • bio-feedback
  • dysphagia
  • swallowing disorders
  • post-stroke
  • deglutition disorders
03

In context

Deglutition Disorders

710 studies on the registry are indexed under Deglutition Disorders; 219 are open to participants now.

This study's enrollment of 17 is below the median of 60 across 471 interventional studies indexed under Deglutition Disorders.

Browse Deglutition Disorders studies →

Lead sponsor

IRCCS San Camillo, Venezia, Italy is the lead sponsor of 48 studies on the registry; 18 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 81 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • first stroke injury
  • single lesion
  • onset from more than six weeks
  • presence of dysphagia (Dysphagia Outcome and Severity Scale ≥ 4)
  • good comprehension ( not below PT 53 in Token Test)
  • good eyesight and hearing, or adequately corrected

Exclusion criteria

Exclusion Criteria:

  • All the elements that hinder a good recording of the electromyographic signal (for instance a cutaneous infection, a wound or a dermatitis in the submandibular area);
  • Severe concomitant illnesses (fever, infections, metabolic problems, serious cardiac insufficiency) that can influence patient's collaboration;
  • Serious dystonia or unintentional movements
  • presence of disorders of consciousness;
  • encephalopathy due to multiple infarcts;
  • inability to sustain the experimental treatment;
  • other neurological diseases (for example Parkinson disease);
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
17 participants (actual)

Study arms

  • Experimental
    "ProComp5 Infiniti" Biofeedback

    Each participant will attend 5 sessions per week for a total duration of 5 weeks. The duration of each session will take 1 hour, including bio-feedback preparation. At the beginning of the bio-feedback session, a surface electrode will be applied to the mylohyoid muscle. The patient will be required to swallow at a given time, with food bolus if possible, and perform maneuvers that favour swallowing strength and efficacy: effortful swallow, supraglottic swallow, and "Masako" maneuver, the first two with bolus administration, if possible. The experimental group will perform this training for 45 minutes, plus they will receive a verbal feedback from the speech and language therapist.

    Device: "ProComp5 Infiniti" Biofeedback

  • Active comparator
    Standard Speech and Language Therapy

    Each participant will attend 5 sessions per week for a total duration of 5 weeks. The patient will be required to swallow at a given time, with food bolus if possible, and perform maneuvers that favour swallowing strength and efficacy: effortful swallow, supraglottic swallow, and "Masako" maneuver, the first two with bolus administration, if possible. The control group will attend this training for 45 minutes, receiving verbal feedback from the speech and language therapist.

    Other: Standard Speech and Language Therapy

Interventions

  • Device"ProComp5 Infiniti" Biofeedback

    Each participant will attend 5 sessions per week for a total duration of 5 weeks. At the beginning of the bio-feedback session, a surface electrode will be applied to the mylohyoid muscle. The computer will produce visual feedback of the muscular activity on the screen. The patient will be required to swallow at a given time, with food bolus if possible, and perform maneuvers that favour swallowing strength and efficacy: they are requested to do classical maneuvers that favour swallowing efficacy that is effortful swallow, supraglottic swallow, and "Masako" maneuver. The experimental group will perform this training for 45 minutes.

  • OtherStandard Speech and Language Therapy

    Each participant will attend 5 sessions per week for a total duration of 5 weeks. The patient will be required to swallow at a given time, with food bolus if possible, and perform maneuvers that favour swallowing strength and efficacy receiving verbal feedback from the speech and language therapist. They are requested to do classical maneuvers that favour swallowing efficacy that is effortful swallow, supraglottic swallow, and "Masako" maneuver. The control group will perform this training for 45 minutes.

06

What researchers measure

Primary outcomes

  1. Change in Functional Oral Intake Scale (FOIS)

    It is a 7-point scale developed to systematically rate the functional severity of dysphagia

    Time frame: Baseline , 4 weeks , finally after 3 months from the end of treatment

Secondary outcomes

  1. Change in Pooling Score (P-score)

    The scale is used during clinical endoscopic evaluation to evaluate severity of swallowing disorder, considering excess residue in the pharynx and larynx.The score (minimum 4 - maximum 11) is obtained by the sum of the scores given to the site of the bolus, the amount and ability to control residue/bolus pooling, the latter assessed on the basis of cough, raclage, number of dry voluntary or reflex swallowing acts.

    Time frame: Baseline , 4 weeks , finally after 3 months from the end of treatment

  2. Change in Penetration-Aspiration Scale (PAS)

    It is a 8-point scale used during endoscopic evaluation that describes and measures the severity of airway invasion during swallowing.

    Time frame: Baseline , 4 weeks , finally after 3 months from the end of treatment

07

Study locations

1 site
  • Sara Nordio
    Venice-Lido, Italy
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 5, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT03247374
Lead sponsor
IRCCS San Camillo, Venezia, Italy
Responsible party
Sara Nordio (Speech and language therapist, IRCCS San Camillo, Venezia, Italy) — Principal investigator
First posted
Aug 11, 2017
Start date
Feb 27, 2018
Primary completion
Oct 1, 2020
Completion
Oct 4, 2022
Last update
Oct 5, 2022

Study contacts

Sara Nordio
principal investigator · IRCCS San Camillo

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion